Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oximation Rearrangement. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101538255B details a greener synthesis for SMIA using butyl acetate, reducing solvent loss and byproducts for reliable pharmaceutical intermediate supply.
Patent CN103102379B details a high-purity epiandrosterone route eliminating hydrogenation. This offers substantial cost reduction in steroid manufacturing and supply chain reliability.